Peter Bou Dib: New Insights on Factor VIII and the Musculoskeletal System
Peter Bou Dib, Key Account Manager at Sino Biological Europe, shared on LinkedIn about a recent article by Antoine Babuty et al, published in Nature Bone Research:
”Hemophilia A (HA) has long been known as a bleeding disorder caused by deficient Factor VIII (FVIII), leading to life-impacting joint bleeds and muscle degeneration.
But what if FVIII’s role extends far beyond just stopping bleeds?
A recently published study using FVIII knockout mice uncovered a surprising story: FVIII deficiency triggers early osteoporosis, disrupted bone vascularization, and muscle abnormalities
a complex musculoskeletal disruption that mirrors patients’ real-life challenges.
Even more promising, intravenous recombinant FVIII treatment not only restored bone density and vascular health but partially reversed muscle metabolic defects.
This suggests FVIII acts as a critical regulator of bone remodeling and muscle metabolism, not just coagulation.
For those living with HA, these insights kindle hope for therapies that protect bones and muscles, improving quality of life beyond bleeding control.
Science is rewriting what we know about FVIII, transforming how we understand, treat, and support hemophilia.
The journey continues.”
Title: Factor VIII restores bone parameters and modulates muscle proteo-metabolome in Factor VIII knockout male mice
Authors: Antoine Babuty, Javier Muñoz-Garcia, Olivier D. Christophe, Laurie Fradet, Manon Taupin, Denis Cochonneau, Emilie Ollivier, Frank Driessler, Claudia Lange, Oleksandr Boychenko, Marie-Françoise Heymann, Dominique Heymann
Read the Full Article on Nature Bone Research
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 23, 2026, 18:27Advancing Gene Therapy Research for Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
-
Jun 23, 2026, 18:17What Every ITP Patient Wants to Know – ITP Support Association
-
Jun 23, 2026, 18:13Ahsan Fareed: Exploring Heart Failure Readmissions in Iron Deficiency Anemia
-
Jun 23, 2026, 18:09Swarnava Roy: Key Findings on Stress Erythropoiesis and Mitochondrial Retention in RBCs
-
Jun 23, 2026, 17:40Hossam El Benawi: How do We Predict Recurrence Post LVT Resoultion?
-
Jun 23, 2026, 17:39Nicolas Gendron: Do We Really Need All These Hemostasis Tests in Patients on DOACs?
-
Jun 23, 2026, 17:33Maité Mulkers: Time is Brain, and One Reason is That a Thrombus Develops Over Time
-
Jun 23, 2026, 17:32Dhargam Aljebouri: Honoured to Be Part of the Young Professionals Breakfast at ISBT 2026
-
Jun 23, 2026, 17:27Dianne E. van der Wal: Phenotype and Activation of the Endothelium in ET at ISTH 2026